[{"id":"ad90e007-a3c1-49d9-b0e8-6b7dc8b99352","acronym":"SGR-2921-101","url":"https://clinicaltrials.gov/study/NCT05961839","created_at":"2023-07-27T18:09:12.809Z","updated_at":"2024-07-02T16:35:07.384Z","phase":"Phase 1","brief_title":"Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome","source_id_and_acronym":"NCT05961839 - SGR-2921-101","lead_sponsor":"Schrödinger, Inc.","biomarkers":" BCL2","pipe":"","alterations":" ","tags":["BCL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SGR-2921"],"overall_status":"Recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 09/27/2023","start_date":" 09/27/2023","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-04-26"}]